|market watch clovis health||1.7||0.7||6736||75|
Clovis Oncology, Inc. is a commercial stage biotechnology company, which engages in the acquisition, development, and commercialization of cancer treatments in the United States, Europe, and other markets.What did Clovis buy for $12m?
Clovis Gains Rights to Pre-Clinical Cancer Program for $12M. Clovis (CLVS) enters into licensing and collaboration agreement with 3B Pharmaceuticals and acquires rights to FAP targeted radiopharmaceutical therapy for developing new cancer treatments.What companies are buying Clover health investments?
Summit Rock Advisors, LP Buys Clover Health Investments Corp, Sells iShares Russell 2000 Value ... Siguler Guff Advisers, Llc Buys International Seaways Inc, Frontier Communications Parent Inc, ... Equitec Proprietary Markets, Llc Buys Stamps.com Inc, B. ...What is clingclover health investments?
Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded in 2014 and is headquartered in Franklin, TN.